Home Previous Slide◀︎ Next Slide▶︎ We act with care to create value in the lives of the people we serve We always strive to find new ways to deliver solutions to people living with severe diseases Everyone deserves to live the best life that they can Current Slide Current Slide Current Slide
At UCB, we believe that everyone deserves to live the best life that they can. That’s why - as a global biopharmaceutical leader - we’re focused on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions. Discover more about us UCBCares® UCBCares® is a personalized service offered by UCB to support people living with a disease and healthcare professionals during their treatment journey with a UCB medicine Contact us here A home for innovation Innovation is a key driver of progress in every aspect of human life including advancing healthcare. Find out more Learn more Empowering women of childbearing age UCB net-zero targets validated by the Science Based Targets initiative Discover our Clinical Studies section UCB Stories & Newsroom Story 6 Dec 2024 What does the future look like for rare genetic epilepsies? Read More Story 28 Nov 2024 UCB net-zero targets validated by the Science Based Targets initiative: a critical step in our... Read More Press release 29 Nov 2024 UCB Focuses on New Launch and Completes Divestment of Mature Product Business in China Read More Press release 27 Nov 2024 UCB presents latest scientific research in epilepsy at American Epilepsy Society (AES) Annual... Read More “Every breakthrough we achieve brings us closer to a world where patients can live better, healthier lives.” Sustainability Sustainability is at the heart of everything we do at UCB, guiding our decisions to positively impact society, support communities, and protect the planet for future generations. Learn more UCB ventures UCB Ventures invests in pioneering companies and technologies that have the potential to transform the lives of people living with severe diseases. Learn more
Story 28 Nov 2024 UCB net-zero targets validated by the Science Based Targets initiative: a critical step in our... Read More
Press release 29 Nov 2024 UCB Focuses on New Launch and Completes Divestment of Mature Product Business in China Read More
Press release 27 Nov 2024 UCB presents latest scientific research in epilepsy at American Epilepsy Society (AES) Annual... Read More